Monday, 29th May

DEFINITION, EPIDEMIOLOGY, BASIC MECHANISMS

16:15 h - 16:30 h

Welcome and Introduction

Jose M Serratosa Fernández. Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
Manuel Toledo Argany. Hospital Universitario Vall d'Hebron, Barcelona, Spain
16:30 h - 17:00 h

Epidemiology and social impact of DRE

Manuel Toledo Argany. Hospital Universitario Vall d'Hebron, Barcelona, Spain
17:00 h - 17:30 h

What is DRE? Concept and definitions

17:30 h - 18:00 h

Basic mechanisms of drug-resistance

18:00 h - 18:30 h

Roundtable and discussion “What is DRE?”

Tuesday, 30th May

FOCAL EPILEPSIES

08:30 h - 09:15 h

Can we predict DRE early in the focal epilepsies?

09:15 h - 10:00 h

Can we avoid DRE with early interventions?

Elinor Ben-Menachem. Sahlgrenska Academym University of Gothenburg, Gothenburg, Sweden
10:00 h - 10:30 h

Optimal pharmacological treatment of DRE

Felix Rosenow. Epilepsy Center Frankfurt Rhine-Main. Center of Neurology and Neurosurgery. Goethe-University Frankfurt, Frankfurt, Germany
10:30 h - 11:00 h

Break

11:00 h - 12:00 h

Symposium

FUTURE ASMs AND THERAPIES

12:00 h - 12:30 h

ASMs under development

12:30 h - 13:00 h

Future therapies

Jose M Serratosa Fernández. Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
13:00 h - 14:00 h

Lunch

IDIOPATHIC GENERALIZED EPILEPSIES

14:00 h - 14:30 h

Drug resistance in IGEs: clinical characteristics

Javier Salas Puig. Hospital Universitario Vall d'Hebron, Barcelona, Spain
14:30 h - 15:00 h

Treatment of drug resistant IGEs

15:00 h - 15:30 h

Treatment of autoimmune epilepsies

Mar Carreño. Hospital Clínic, Barcelona, Spain
15:30 h - 16:00 h

Break

16:00 h - 17:00 h

Symposium

Wednesday, 31st May

DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHIES (DEEs)

08:30 h - 09:00 h

Clinical characteristics of the main types of DEEs

Elena Gardella. Danish Epilepsy Center. University of Copenhagen. Copenhagen, Denmark.
09:00 h - 09:30 h

Treatment of Dravet disease and Lennox-Gastaut syndrome

09:30 h - 10:00 h

Treatment of other DEEs

Stephan Auvin. Robert Debré Hospital, Public Hospital Network of Paris, Paris, France
10:00 h - 10:30 h

Break

10:30 h - 11:30 h

Symposium

SPECIAL LECTURE

11:30 h - 12:15 h

Comorbidities, mortality, and SUDEP in DRE

Torbjörn Thompson. Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
12:15 h - 12:45 h

Comprehensive evaluation test

12:45 h - 13:00 h

Conclusions and awards

Jose M Serratosa Fernández. Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
Manuel Toledo Argany. Hospital Universitario Vall d'Hebron, Barcelona, Spain